Chang Min Choi Selected Research

Chang Min Choi Research Topics

Disease

17	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2023 - 12/2013
12	Lung Neoplasms (Lung Cancer) 03/2022 - 12/2013
9	Neoplasms (Cancer) 01/2023 - 01/2014
6	Adenocarcinoma 01/2021 - 07/2015
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2021 - 01/2015
2	Neoplasm Metastasis (Metastasis) 07/2023 - 06/2023
2	Carcinogenesis 07/2015 - 12/2013
1	Tuberculosis (Tuberculoses) 11/2023
1	Venous Thromboembolism 01/2019
1	Hemorrhage 01/2019
1	Pleural Effusion (Pleural Effusions) 12/2018
1	Sepsis (Septicemia) 01/2018
1	Pulmonary Embolism 11/2016
1	Alzheimer Disease (Alzheimer's Disease) 08/2015
1	Altitude Sickness (Mountain Sickness) 03/2014
1	Lymphoma (Lymphomas) 12/2013
1	Airway Obstruction (Choking) 10/2013
1	Cicatrix (Scar) 12/2007

Drug/Important Bio-Agent (IBA)

7	ErbB Receptors (EGF Receptor)IBA 11/2023 - 12/2013
6	AfatinibIBA 11/2023 - 01/2018
5	Tyrosine Kinase InhibitorsIBA 03/2022 - 12/2013
4	Immune Checkpoint InhibitorsIBA 07/2023 - 01/2020
2	osimertinibIBA 10/2023 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 08/2019
2	DNA (Deoxyribonucleic Acid)IBA 12/2018 - 11/2017
2	Proteins (Proteins, Gene)FDA Link 07/2015 - 01/2015
2	silmitasertibIBA 03/2015 - 01/2014
1	atezolizumabIBA 01/2023
1	Dalteparin (Dalteparin Sodium)FDA Link 01/2019
1	AnticoagulantsIBA 01/2019
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2019
1	RivaroxabanIBA 01/2019
1	Cell-Free Nucleic AcidsIBA 12/2018
1	human ERBB2 proteinIBA 01/2018
1	MucinsIBA 09/2016
1	Gefitinib (Iressa)FDA Link 10/2015
1	Carboplatin (JM8)FDA LinkGeneric 10/2015
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2015
1	Amyloid beta-PeptidesIBA 08/2015
1	Amino Acids FDA Link 08/2015
1	Anaplastic Lymphoma KinaseIBA 07/2015
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 07/2015
1	geldanamycinIBA 07/2015
1	17- (dimethylaminoethylamino)- 17- demethoxygeldanamycinIBA 07/2015
1	TOR Serine-Threonine KinasesIBA 07/2015
1	Eukaryotic Initiation Factor-4EIBA 07/2015
1	PeroxiredoxinsIBA 01/2015
1	AntioxidantsIBA 01/2015
1	Indicators and Reagents (Reagents)IBA 01/2015
1	Hemoglobins (Hemoglobin)IBA 03/2014
1	Erythropoietin FDA Link 03/2014
1	Casein Kinase II (Casein Kinase 2)IBA 01/2014
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2013
1	CrizotinibIBA 12/2013
1	Phosphotransferases (Kinase)IBA 12/2013
1	Tuberculin (PPD)IBA 12/2007

Therapy/Procedure

7	Therapeutics 01/2022 - 12/2013
3	Radiotherapy 07/2023 - 01/2021
3	Immunotherapy 01/2023 - 01/2020
3	Drug Therapy (Chemotherapy) 01/2021 - 10/2015
1	Pneumonectomy (Lung Volume Reduction) 01/2018
1	Catheters 01/2018
1	Injections 03/2014
1	Extracorporeal Membrane Oxygenation 10/2013